| Literature DB >> 28352575 |
Syed Aun Muhammad1, Safia Ahmed2.
Abstract
A novel thermophilic bacterial strain of the genus Aeribacillus was isolated from Thar Dessert Pakistan. This strain showed significant antibacterial activity against Micrococcus luteus, Staphylococcus aureus, and Pseudomonasaeruginosa. The strain coded as 'SAT4' resembled with Aeribacillus pallidus in the morphological, biochemical and molecular tests. The production of antibacterial metabolites by SAT4 was optimized. These active metabolites were precipitated by 50% ammonium sulphate and purified through sephadex G-75 gel permeation chromatography and reverse phase HPLC. The molecular weight of 37 kDa was examined by SDS-PAGE. The structural elucidation of the purified product was studied by FTIR, 1H and 13C NMR. The X-ray diffractions study showed that the crystals belonged to the primitive orthorhombic lattice (a = 12.137, b = 13.421, c = 14.097 Å) and 3D structure (proposed name: Aeritracin) was determined. This new peptide antibacterial molecule can get a position in pharmaceutical and biotechnological industrial research.Entities:
Keywords: Aeribacillus pallidus SAT4; Antibiotics; Characterization; Production
Year: 2015 PMID: 28352575 PMCID: PMC4980744 DOI: 10.1016/j.btre.2015.09.003
Source DB: PubMed Journal: Biotechnol Rep (Amst) ISSN: 2215-017X
Antibacterial activity of selected thermophilic bacterial isolates against indicator bacterial strains.
| Indicator bacterial species | Zone of inhibitions shown by the thermophilic bacterial isolates (mm) | ||||
|---|---|---|---|---|---|
| SAT1 | SAT2 | SAT3 | SAT4 | SAT5 | |
| 2 | 2 | 4 | 25 | 6 | |
| 1 | 2 | 2 | 22 | 6 | |
| 0 | 0 | 0 | 16 | 1 | |
| 0 | 0 | 0 | 5 | 0 | |
Taxonomic characterization of bacterial isolates SAT4.
| Test analysis | Types | Features | Result |
|---|---|---|---|
| Microscopic examination | Gram’s staining | + | |
| Shape | Rods arranged in pairs | ||
| Morphological characteristics | Spore formation | + | |
| Motility | + | ||
| Macroscopic appearance: colony morphology | Color | White to off | |
| Elevation | Flat | ||
| Colony shape | Circular | ||
| Margins | Entire | ||
| Biochemical | API 50CHB Tests that were positive for | ||
| GLY GLU FRU MNE MAN SOR MDG NAG AMY ARB ESC SAL CEL SAC TRE LFUC | |||
| API 20E Tests that were positive for | |||
| ONPG CIT GEL INO RHA ARA | |||
| Significant Taxon 98.4 % | |||
| Molecular | Universal primers F27 and R907 | ||
| Characteristics | 100% homology with | ||
Indications: + sign indicates the positive reaction (color change), GLY: glycerol; GLU: d-glucose; FRU: d-fructose; MNE: d-mannose; MAN: d-mannitol; SOR, MDG, NAG: N-acetylglucosamine; AMY: amygdalin; ARB: arbutin; ESC: esculin ferric citrate; SAL: salicin; CEL: d-cellobiose; SAC: d-sucrose; TRE: trehalose; LFUC: l-fucose.
Only the tests with a positive result are included here (remaining tests were negative).
Only the tests with a positive result are included here (remaining tests were negative). ONPG: 2-nitrophenyl-ß-d-galactopyranoside; CIT: trisodium citrate; GEL: gelatin; INO: inositol; RHA: l-rhamnose; ARA: l-arabinose.
Biochemical tests: API kit system with percentage of positive tests after 24 h of incubation.
Fig. 1Evolutionary and phylogenetic relationship of Aeribacillus pallidus SAT4 with 47 taxa (linearized).
Fig. 2Optimization of antibacterial compound production by Aeribacillus pallidus SAT4 (a) effect of Incubation time (hours) (b) various pH values (c) glucose concentrations, used as carbon source (d) glutamic acid concentrations, used as nitrogen source (e) Effect of agitation (rpm) rates (f) Effect of different temperatures.
Fig. 3SDS-PAGE analysis (La: Ladder; Lane 1: protein sample).
Prominent FT-IR bands for antibacterial peptide compound.
| Compound | FT-IR (cm−1) |
|---|---|
| Thermostable peptide antibacterial compound produced by | 3600–3650 stretching (O—H), 2990–2800 stretching (—C—H sp3), 2359 stretching (—N |
Fig. 4(a) 2D structure [2-(9-((1H-imidazol-4-yl)methyl)-3-(2-amino-2-oxoethyl)-21-(2-(2-amino-4-(2-aminoacetamido)-4-oxobutanamido)-3-phenylpropanamido)-18-(3-aminopropyl)-12-benzyl-15-(sec-butyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-6-yl) acetic acid] of antibacterial compound (proposed name: Aeritracin) obtained from thermophilic Aeribacillus pallidus SAT4 (b) The 3D crystal structure of antibacterial compound obtained from Aeribacillus pallidus SAT4 belong to the primitive orthorhombic lattice with the cell parameters a = 12.137, b = 13.421, c = 14.097 Å.
Data processing statistics of antibacterial compound obtained by Aeribacillus pallidus SAT4 was identified and calculated from a single crystal source using a STOE-IPDS II equipped with an Oxford Cryostream low-temperature unit Germany.
| Molecular formula | C55 H82 N16 O17 |
| Molecular weight | 1,239.37 |
| Molecular composition | C: 0.533, H: 0.067, N: 0.181, O: 0.219 |
| Crystal system | Triclinic |
| Space group | P-1; Shoenflies: C1-1, |
| Alpha = 84.269 (5) Å | |
| Beta = 81.71 (5) Å | |
| Gamma = 80.86 (5) Å | |
| Absorption coefficient | 0.34 mm–1 |
| No. of reflections collected/unique | 7955 |
| No. of reflections used [ | 6045 |
| Parameters | 474 |
| Final | R1 = 0.0282, wR2 = 0.0677 |
| R1 = 0.0394, wR2 = 0.0750 | |
| Structure determination | SIR97, SHELXL97 and WinGX |
| Equipment | STOE-IPDS II equipped with an Oxford Cryostream low-temperature unit |
Thermostability analysis of cell free supernatant and pure antibacterial compound at various temperatures against Micrococcus luteus and Staphylococcus aureus as indicator bacterial strains.
| Sample | Zone of inhibition | Temperature (°C) | Activity against | ||||
|---|---|---|---|---|---|---|---|
| Zone of inhibition (mm) | % age loss of activity | Zone of inhibition (mm) | % age loss of activity* | ||||
| Cell free supernatant | 22 | 25 | 45 | 14 | 36 | 12 | 52 |
| 50 | 18 | 18 | 15 | 40 | |||
| 55 | 22 | 0.00 | 18 | 28 | |||
| 60 | 10 | 55 | 8 | 68 | |||
| 45 | 18 | 18 | 20 | 20 | |||
| Analysis after purification | 50 | 15 | 31 | 16 | 36 | ||
| 55 | 12 | 45 | 12 | 52 | |||
| 60 | 8 | 63 | 10 | 60 | |||
Formula: A0 − Af/A0 × 100, where A0: activity control; Af: activity after treatment.
0.1% concentration of purified antibacterial compound produced by Aeribacillus pallidus SAT4 was used before treatment.